|
1
|
Cassidy J, Bissett D, Spence RAJ, Payne M
and Morris-Stiff G: Oxford Handbook of Oncology. 4th edition.
Oxford University Press, New York, NY, 2015.
|
|
2
|
Rougier P, Legoux JL, Lepage C and Michel
P: Hepato-gastroenterologists and oncologists are complementary in
the management of digestive cancers. Dig Liver Dis. 43:583–584.
2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Jooste V, Remontet L, Colonna M, Belot A,
Launoy G, Binder F, Faivre J and Bouvier AM: Trends in the
incidence of digestive cancers in France between 1980 and 2005 and
projections for the year 2010. Eur J Cancer Prev. 20:375–380.
2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Chauvenet M, Lepage C, Jooste V, Cottet V,
Faivre J and Bouvier AM: Prevalence of patients with colorectal
cancer requiring follow-up or active treatment. Eur J Cancer.
45:1460–1465. 2009.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Chabner BA and Longo DL: Harrison's Manual
of Oncology. 2nd edition. McGraw-Hill Education, 2014.
|
|
6
|
Hockl PF, Wolosiuk A, Pérez-Sáez JM,
Bordoni AV, Croci DO, Toum-Terrones Y, Soler-Illia GJ and
Rabinovich GA: Glyco-nano-oncology: Novel therapeutic opportunities
by combining small and sweet. Pharmacol Res. 109:45–54.
2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Thakor AS and Gambhir SS: Nanooncology:
The future of cancer diagnosis and therapy. CA Cancer J Clin.
63:395–418. 2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Sharma H, Mishra PK, Talegaonkar S and
Vaidya B: Metal nanoparticles: A theranostic nanotool against
cancer. Drug Discov Today. 20:1143–1151. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
de Oliveira R, Zhao P, Li N, de Santa
Maria LC, Vergnaud J, Ruiz J, Astruc D and Barratt G: Synthesis and
in vitro studies of gold nanoparticles loaded with docetaxel. Int J
Pharm. 454:703–711. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kodiha M, Wang YM, Hutter E, Maysinger D
and Stochaj U: Off to the organelles-killing cancer cells with
targeted gold nanoparticles. Theranostics. 5:357–370.
2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gu YJ, Cheng J, Lin CC, Lam YW, Cheng SH
and Wong WT: Nuclear penetration of surface functionalized gold
nanoparticles. Toxicol Appl Pharmacol. 237:196–204. 2009.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ryu JH, Lee S, Son S, Kim SH, Leary JF,
Choi K and Kwon IC: Theranostic nanoparticles for future
personalized medicine. J Control Release. 190:477–484.
2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ivošev V, Sánchez GJ, Stefancikova L,
Haidar DA, González Vargas CR, Yang X, Bazzi R, Porcel E, Roux S
and Lacombe S: Uptake and excretion dynamics of gold nanoparticles
in cancer cells and fibroblasts. Nanotechnology.
31(135102)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Huay Y, Zhang Y, Xiong X, Das S,
Bhattacharya R and Mukherjee P: Gold Nanoparticles sensitize
pancreatic cancer cells to gemcitabine. Cell Stress. 3:267–279.
2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Roy I: Gold nanoparticle-enhanced
photodynamic therapy from photosensitiser-entrapped ormosil
nanoparticles. J Nanosci Nanotechnol. 19:6942–6948. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhang F, Han X, Hu Y, Wang S, Liu S, Pan
X, Wang H, Ma J, Wang W, Li S, et al: Interventional photothermal
therapy enhanced brachytherapy: A new strategy to fight deep
pancreatic cancer. Adv Sci (Weinh). 6(1801507)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Qiu W, Chen R, Chen X, Zhang H, Song L,
Cui W, Zhang J, Ye D, Zhang Y and Wang Z: Oridonin-loaded and
GPC1-targeted gold nanoparticles for multimodal imaging and therapy
in pancreatic cancer. Int J Nanomedicine. 13:6809–6827.
2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Sudimack J and Lee RJ: Targeted drug
delivery via the folate receptor. Adv Drug Deliv Rev. 41:147–162.
2000.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Muller RH and Keck CM: Challenges and
solutions for the delivery of biotech drugs-a review of drug
nanocrystal technology and lipid nanoparticles. J Biotechnol.
113:151–170. 2004.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Nayak D, Minz AP, Ashe S, Rauta PR, Kumari
M, Chopra P and Nayak B: Synergistic combination of antioxidants,
silver nanoparticles and chitosan in a nanoparticle based
formulation: Characterization and cytotoxic effect on MCF-7 breast
cancer cell lines. J Colloid Interface Sci. 470:142–152.
2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Chaudhury A and Das S: Recent advancement
of chitosan-based nanoparticles for oral controlled delivery of
insulin and other therapeutic agents. AAPS PharmSciTech. 12:10–20.
2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tomşa AM, Picoş A, Picoş AM and Răchişan
AL: Mitochondrial nanotargeting in malignancies (Review). Exp Ther
Med. 20:3444–3451. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Coelho SC, Reis DP, Pereira MC and Coelho
MAN: Doxorubicin and varlitinib delivery by functionalized gold
nanoparticles against human pancreatic adenocarcinoma.
Pharmaceutics. 11(551)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Steckiewicz KP, Barcinska E, Sobczak K,
Tomczyk E, Wojcik M and Inkielewicz-Stepniak I: Assessment of
Anti-Tumor potential and safety of application of Glutathione
stabilized Gold Nanoparticles conjugated with Chemotherapeutics.
Int J Med Sci. 17:824–833. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Banstola A, Pham TT, Jeong JH and Yook S:
Polydopamine-tailored paclitaxel-loaded polymeric microspheres with
adhered NIR-controllable gold nanoparticles for chemo-phototherapy
of pancreatic cancer. Drug Deliv. 26:629–640. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Alarfaj NA, El-Tohamy MF and Oraby HF: CA
19-9 pancreatic tumor marker fluorescence immunosensing detection
via immobilized carbon quantum dots conjugated gold nanocomposite.
Int J Mol Sci. 19(1162)2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Han X, Li Y, Xu Y, Zhao X, Zhang Y, Yang
X, Wang Y, Zhao R, Anderson G, Zhao Y and Nie G: Reversal of
pancreatic desmoplasia by re-educating stellate cells with a tumour
microenvironment-activated nanosystem. Nat Commun.
9(3390)2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Lin L, Fan Y, Gao F, Jin L, Li D, Sun W,
Li F, Qin P, Shi Q, Shi X and Du L: UTMD-promoted co-delivery of
gemcitabine and miR-21 inhibitor by dendrimer-entrapped gold
nanoparticles for pancreatic cancer therapy. Theranostics.
8:1923–1939. 2018.PubMed/NCBI View Article : Google Scholar
|
